Bart Marescau
Affiliations: | Universiteit Antwerpen (Belgium) |
Area:
Toxicology, Neuroscience BiologyGoogle:
"Bart Marescau"Mean distance: 53433
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lee EK, Hu C, Bhargava R, et al. (2013) AAV-based gene therapy prevents neuropathology and results in normal cognitive development in the hyperargininemic mouse. Gene Therapy. 20: 785-96 |
| Deignan JL, De Deyn PP, Cederbaum SD, et al. (2010) Guanidino compound levels in blood, cerebrospinal fluid, and post-mortem brain material of patients with argininemia. Molecular Genetics and Metabolism. 100: S31-6 |
| Eloot S, van Biesen W, Dhondt A, et al. (2009) Impact of increasing haemodialysis frequency versus haemodialysis duration on removal of urea and guanidino compounds: a kinetic analysis. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 24: 2225-32 |
| Levillain O, Marescau B, Possemiers I, et al. (2008) Accumulation of methylguanidine and changes in guanidino compound levels in plasma, urine, and kidneys of furosemide-treated rats. Metabolism: Clinical and Experimental. 57: 802-10 |
| Taes YE, Marescau B, De Vriese A, et al. (2008) Guanidino compounds after creatine supplementation in renal failure patients and their relation to inflammatory status. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 23: 1330-5 |
| Deignan JL, Marescau B, Livesay JC, et al. (2008) Increased plasma and tissue guanidino compounds in a mouse model of hyperargininemia. Molecular Genetics and Metabolism. 93: 172-8 |
| Eloot S, Torremans A, De Smet R, et al. (2007) Complex compartmental behavior of small water-soluble uremic retention solutes: evaluation by direct measurements in plasma and erythrocytes. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 50: 279-88 |
| Torremans A, Marescau B, Kränzlin B, et al. (2006) Biochemical validation of a rat model for polycystic kidney disease: comparison of guanidino compound profile with the human condition. Kidney International. 69: 2003-12 |
| Van Dam D, Marescau B, Cremers T, et al. (2005) Regional distribution of biogenic amines, amino acids and cholinergic markers in the CNS of the C57BL/6 strain. Amino Acids. 28: 377-87 |
| Torremans A, Marescau B, Possemiers I, et al. (2005) Biochemical and behavioural phenotyping of a mouse model for GAMT deficiency. Journal of the Neurological Sciences. 231: 49-55 |